Spreading of alpha-synuclein - relevant or epiphenomenon?

被引:33
|
作者
Killinger, Bryan A. [1 ]
Kordower, Jeffrey H. [1 ]
机构
[1] Rush Univ, Med Ctr, Dept Neurol Sci, 1735 West Harrison St, Chicago, IL 60612 USA
关键词
Braak hypothesis; neurodegeneration; prion; synucleinopathy; TO-NEURON TRANSMISSION; LEWY BODY PATHOLOGY; PARKINSONS-DISEASE; AXONAL-TRANSPORT; GASTROINTESTINAL-TRACT; OLFACTORY DYSFUNCTION; FIBRILS; BRAIN; AGGREGATION; INJECTION;
D O I
10.1111/jnc.14779
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The intracellular accumulation of misfolded alpha-synuclein pathology, termed Lewy pathology, throughout the brain is a phenomenon central to Parkinson's disease pathogenesis. In recent years it has become apparent that Lewy pathology can spread from neuron-to-neuron and between interconnected brain regions. Understanding the phenomenon of Lewy pathology propagation holds great promise in its explanatory power to determine the etiology of Parkinson's disease and related synucleinopathies. However, it remains to be seen if the spread of Lewy pathology is critical for driving this disease. Here we discuss the spreading of Lewy pathology while highlighting some important concepts and experimental observations. We conclude that further studies are required to determine if, and how, the spreading behavior of Lewy pathology is involved in Parkinson's disease.
引用
收藏
页码:605 / 611
页数:7
相关论文
共 50 条
  • [41] Alpha-Synuclein in the Appendiceal Mucosa of Neurologically Intact Subjects
    Gray, Madison T.
    Munoz, David G.
    Gray, Douglas A.
    Schlossmacher, Michael G.
    Woulfe, John M.
    MOVEMENT DISORDERS, 2014, 29 (08) : 991 - 998
  • [42] Alpha-Synuclein: From Early Synaptic Dysfunction to Neurodegeneration
    Ghiglieri, Veronica
    Calabrese, Valeria
    Calabresi, Paolo
    FRONTIERS IN NEUROLOGY, 2018, 9
  • [43] Alpha-Synuclein in Peripheral Tissues in Parkinson's Disease
    Ma, Ling-Yan
    Liu, Gen-Liang
    Wang, Dong-Xu
    Zhang, Mei-Mei
    Kou, Wen-Yi
    Feng, Tao
    ACS CHEMICAL NEUROSCIENCE, 2019, 10 (02): : 812 - 823
  • [44] Does Human Alpha-Synuclein Behave Like Prions?
    Siddique, Yasir Hasan
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2021, 20 (06) : 480 - 486
  • [45] Molecular Chaperones, Alpha-Synuclein, and Neurodegeneration
    Stephan N. Witt
    Molecular Neurobiology, 2013, 47 : 552 - 560
  • [46] Alpha-synuclein oligomers: a new hope
    Bengoa-Vergniory, Nora
    Roberts, Rosalind F.
    Wade-Martins, Richard
    Alegre-Abarrategui, Javier
    ACTA NEUROPATHOLOGICA, 2017, 134 (06) : 819 - 838
  • [47] Alpha-synuclein and tau: teammates in neurodegeneration?
    Moussaud, Simon
    Jones, Daryl R.
    Moussaud-Lamodiere, Elisabeth L.
    Delenclos, Marion
    Ross, Owen A.
    McLean, Pamela J.
    MOLECULAR NEURODEGENERATION, 2014, 9 : 43
  • [48] Molecular Chaperones, Alpha-Synuclein, and Neurodegeneration
    Witt, Stephan N.
    MOLECULAR NEUROBIOLOGY, 2013, 47 (02) : 552 - 560
  • [49] Features of alpha-synuclein that could explain the progression and irreversibility of Parkinson's disease
    Gallegos, Scarlet
    Pacheco, Carla
    Peters, Christian
    Opazo, Carlos M.
    Aguayo, Luis G.
    FRONTIERS IN NEUROSCIENCE, 2015, 9
  • [50] Revisiting Alpha-Synuclein Pathways to Inflammation
    Lyra, Patricia
    Machado, Vanessa
    Rota, Silvia
    Chaudhuri, Kallol Ray
    Botelho, Joao
    Mendes, Jose Joao
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (08)